| Product NDC: | 68220-140 |
| Proprietary Name: | Cortifoam |
| Non Proprietary Name: | hydrocortisone acetate |
| Active Ingredient(s): | 1500 mg/15g & nbsp; hydrocortisone acetate |
| Administration Route(s): | RECTAL |
| Dosage Form(s): | AEROSOL, FOAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68220-140 |
| Labeler Name: | Alaven Pharmaceutical LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017351 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19820212 |
| Package NDC: | 68220-140-15 |
| Package Description: | 1 CONTAINER in 1 CARTON (68220-140-15) > 15 g in 1 CONTAINER |
| NDC Code | 68220-140-15 |
| Proprietary Name | Cortifoam |
| Package Description | 1 CONTAINER in 1 CARTON (68220-140-15) > 15 g in 1 CONTAINER |
| Product NDC | 68220-140 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | hydrocortisone acetate |
| Dosage Form Name | AEROSOL, FOAM |
| Route Name | RECTAL |
| Start Marketing Date | 19820212 |
| Marketing Category Name | NDA |
| Labeler Name | Alaven Pharmaceutical LLC |
| Substance Name | HYDROCORTISONE ACETATE |
| Strength Number | 1500 |
| Strength Unit | mg/15g |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |